๐Ÿ•ต๏ธ IGC Pharma, Inc. ($IGC)

SEC insider & ownership activity, last 12 months ยท CIK 1326205 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Reg FD disclosure (7.01)Jul 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 13, 2026 filing โ†—
Material agreement (1.01)Jun 30, 2026 filing โ†—
Unregistered equity sale (3.02)Jun 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 30, 2026 filing โ†—
Material agreement (1.01)Jun 5, 2026 filing โ†—
New financial obligation (2.03)Jun 5, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 5, 2026 filing โ†—
Material agreement (1.01)Apr 14, 2026 filing โ†—
New financial obligation (2.03)Apr 14, 2026 filing โ†—
Unregistered equity sale (3.02)Apr 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 14, 2026 filing โ†—
Other events (8.01)Mar 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 30, 2026 filing โ†—
Material agreement (1.01)Mar 6, 2026 filing โ†—
New financial obligation (2.03)Mar 6, 2026 filing โ†—
Unregistered equity sale (3.02)Mar 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing โ†—
Material agreement (1.01)Jan 5, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 5, 2026 filing โ†—
Charter/bylaw changes (5.03)Dec 30, 2025 filing โ†—
Charter/bylaw changes (5.03)Dec 12, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 12, 2025 filing โ†—
Acquisition or disposition (2.01)Nov 13, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 13, 2025 filing โ†—
Shareholder vote (5.07)Oct 10, 2025 filing โ†—
Other events (8.01)Oct 10, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 10, 2025 filing โ†—
Material agreement (1.01)Oct 1, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 1, 2025 filing โ†—